George J Christ Selected Research

5-hydroxymethyl tolterodine

8/2010	Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction.
7/2010	Urodynamic evaluation of fesoterodine metabolite, doxazosin and their combination in a rat model of partial urethral obstruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George J Christ Research Topics

Disease

12	Wounds and Injuries (Trauma) 11/2022 - 06/2012
5	Erectile Dysfunction 12/2009 - 07/2002
4	Infections 01/2006 - 08/2002
3	Cardiomyopathies (Cardiomyopathy) 04/2005 - 10/2002
2	Ischemia 01/2022 - 01/2013
2	Inflammation (Inflammations) 01/2019 - 07/2008
2	Fibrosis (Cirrhosis) 01/2019 - 01/2017
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/2010 - 07/2010
2	Urethral Obstruction 08/2010 - 07/2010
2	Body Weight (Weight, Body) 07/2010 - 02/2004
2	Hyperglycemia 07/2008 - 05/2007
2	Urologic Diseases (Urinary Tract Disease) 02/2007 - 02/2004
2	Heart Diseases (Heart Disease) 04/2005 - 08/2002
2	Chagas Disease (American Trypanosomiasis) 09/2004 - 11/2002
1	Reperfusion Injury 01/2022
1	Atrophy 01/2021
1	Lacerations 01/2017
1	Hypoxia (Hypoxemia) 01/2013
1	Fatigue 01/2013
1	False Aneurysm (Pseudoaneurysm) 09/2012
1	Pathologic Constriction (Stenosis) 09/2012
1	Lower Urinary Tract Symptoms 08/2010
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 07/2010
1	Overactive Urinary Bladder (Overactive Bladder) 07/2010
1	Hyperplasia 11/2008
1	Diabetes Mellitus 07/2008
1	Diabetes Complications 07/2008
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 05/2008
1	Urinary Bladder Diseases (Bladder Diseases) 05/2008
1	Spasm (Spasms) 08/2002

Drug/Important Bio-Agent (IBA)

3	Biocompatible Materials (Biomaterials)IBA 12/2021 - 01/2013
3	Endothelin-1 (Endothelin 1)IBA 04/2005 - 08/2002
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2013
2	HydrogelsIBA 01/2022 - 01/2017
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 08/2010 - 07/2010
2	5-hydroxymethyl tolterodineIBA 08/2010 - 07/2010
2	Doxazosin (Cardura)FDA LinkGeneric 08/2010 - 07/2010
2	fesoterodine FDA Link 08/2010 - 07/2010
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2006 - 09/2004
2	phosphoramidonIBA 11/2002 - 08/2002
1	SolutionsIBA 01/2022
1	Decellularized Extracellular MatrixIBA 12/2021
1	LipidsIBA 01/2019
1	Keratins (Keratin)IBA 01/2017
1	Macrophage Colony-Stimulating FactorIBA 01/2017
1	Insulin-Like PeptidesIBA 01/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	GlycogenIBA 01/2013
1	Muscarinic AntagonistsIBA 07/2010
1	AS 35IBA 07/2010
1	Estrogens (Estrogen)FDA Link 11/2008
1	Proteins (Proteins, Gene)FDA Link 07/2008
1	Extracellular Matrix ProteinsIBA 07/2008
1	Streptozocin (Streptozotocin)FDA Link 07/2008
1	Uroplakin IIIBA 05/2008
1	Dihydrotachysterol (AT 10)IBA 05/2007
1	Biomarkers (Surrogate Marker)IBA 02/2007
1	CyclinsIBA 01/2006
1	Caveolin 1IBA 01/2006
1	Small Interfering RNA (siRNA)IBA 09/2005
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2004
1	JNK Mitogen-Activated Protein KinasesIBA 09/2004
1	p38 Mitogen-Activated Protein KinasesIBA 09/2004
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2004
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 09/2004
1	Mitogen-Activated Protein KinasesIBA 09/2004
1	Carbachol (Carbastat)FDA Link 02/2004
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 05/2003
1	Neprilysin (Neutral Endopeptidase)IBA 11/2002
1	Peptides (Polypeptides)IBA 11/2002
1	Caveolin 3IBA 10/2002
1	Metalloproteases (Metalloproteinases)IBA 08/2002
1	Endothelin-Converting EnzymesIBA 08/2002

Therapy/Procedure

9	Therapeutics 11/2022 - 07/2002
2	Drug Therapy (Chemotherapy) 02/2006 - 07/2002
1	Tourniquets 01/2022
1	Denervation 01/2021
1	Injections 01/2017
1	Ligation 01/2013
1	Punctures 09/2012
1	Contraindications 02/2004